Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
McKesson Corporation

McKesson Corporation (MCK) Stock Overview

Explore McKesson Corporation’s financial performance, market position, analyst ratings, and future outlook.

MCK●NYSE
HealthcareMedical - Distribution
$838.75
$14.96(1.75%)
U.S. Market opens in 1h 26m

McKesson Corporation (MCK)

Meyka AI Score

Z

Key Financials

Market Cap98.2B
P/E Ratio22.58
EPS (TTM)$40.82
ROE-1.94%
Fundamental Analysis

AI Price Forecasts

1 Month$903.62
3 Months$953.58
1 Year Target$902.76

MCK Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of McKesson Corporation (NYSE: MCK) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, McKesson Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MCK on the NYSE shows an RSI of 49.40, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $902.76 for the NYSE listing.

Key metrics behind McKesson Corporation's NYSE-traded stock include a P/E ratio of 22.58 and a market capitalization of 98.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MCK on the NYSE.

Price Performance (NYSE: MCK)

1-Day Change
-1.74%
5-Day Change
-2.43%
1-Month Change
0.89%
3-Month Change
11.15%
6-Month Change
-11.47%
Year-to-Date (YTD) Change
2.26%
1-Year Change
19.33%
3-Year Change
96.98%
5-Year Change
318.56%
All-Time (Max) Change
4983.88%

Contact Information

https://www.mckesson.com
972 446 4800
6555 State Highway 161, Irving, TX, 75039

Company Facts

423,000 Employees
IPO DateNov 10, 1994
CountryUS
Actively Trading

Frequently Asked Questions